KeyCorp upgraded shares of Halyard Health (NYSE:HYH) from a sector weight rating to an overweight rating in a research note released on Thursday morning, MarketBeat.com reports.
A number of other brokerages have also issued reports on HYH. ValuEngine upgraded shares of Halyard Health from a hold rating to a buy rating in a research note on Wednesday, February 28th. Zacks Investment Research lowered shares of Halyard Health from a buy rating to a hold rating in a research note on Wednesday, January 3rd. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $49.33.
NYSE:HYH traded up $0.98 on Thursday, reaching $46.43. 441,177 shares of the company’s stock were exchanged, compared to its average volume of 410,573. The company has a debt-to-equity ratio of 0.45, a current ratio of 2.98 and a quick ratio of 2.74. The firm has a market capitalization of $2,110.93, a PE ratio of 20.08, a price-to-earnings-growth ratio of 5.27 and a beta of 1.62. Halyard Health has a 52-week low of $35.24 and a 52-week high of $50.99.
Several hedge funds have recently added to or reduced their stakes in HYH. LPL Financial LLC purchased a new stake in shares of Halyard Health during the fourth quarter worth approximately $206,000. Jane Street Group LLC purchased a new stake in shares of Halyard Health during the third quarter worth approximately $211,000. Xact Kapitalforvaltning AB purchased a new position in Halyard Health in the fourth quarter valued at approximately $250,000. Ramsey Quantitative Systems purchased a new position in Halyard Health in the fourth quarter valued at approximately $266,000. Finally, ING Groep NV increased its stake in Halyard Health by 23.2% in the fourth quarter. ING Groep NV now owns 7,060 shares of the medical instruments supplier’s stock valued at $326,000 after purchasing an additional 1,329 shares during the last quarter. Hedge funds and other institutional investors own 91.32% of the company’s stock.
WARNING: “Halyard Health (HYH) Upgraded to “Overweight” by KeyCorp” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.tickerreport.com/banking-finance/3335788/halyard-health-hyh-upgraded-to-overweight-by-keycorp.html.
Halyard Health Company Profile
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.